Status: Not yet recruiting
SpO2 Infant and Pediatric Study
This study evaluates the pulse oximetry (SpO₂) sensor for clinical performance, form, and fit in hospitalized infants and children (28 days to 12 years). It compares SpO₂ measurements from the device to arterial oxygen saturation (SaO₂) values from arterial CO-oximetry, and assesses the reliability of usable data, performance across skin tones, and user feedback.
Participants needed: 180
Trial details
Age: 29-12Biological sex: AllType: InterventionalSponsor: GE HealthcareUpdated: Jul 1, 2026Locations: 1
Eligibility criteria
subjects are 1-23 months (infant cohort) or 2-12 years old (child cohort) [+1]
Fractional Methemoglobinemia (FMetHb >2%) or Fractional carboxyhemoglobinemia (F... [+9]